...
首页> 外文期刊>Medicine. >Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
【24h】

Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?

机译:炎性标志物能否预测同步性大肠癌患者的预后?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Systematic inflammatory response markers are considered as the most informative prognostic factors in many types of cancer. However, in synchronous colorectal cancer (synCRC), the prognostic value of inflammatory markers, including prognostic nutritional index (PNI), neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (d-NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR), had rarely been evaluated. Thus, this present study reviewed our consecutive patients with synCRC to investigate the prognostic value of those factors. The primary endpoint was overall survival (OS), and disease-free survival (DFS) was considered as the secondary endpoint. Receiver-operating characteristic curve analysis was conducted to determine optimal cutoff levels for the 5 markers. Kaplan–Meier survival curves and Cox proportional hazards models were applied to assess the relationship between OS, DFS, and inflammatory markers. In total, 114 patients with pathologically confirmed synCRC at initial diagnosis were identified among 5742 patients who underwent surgery for colorectal cancer from October 2009 to May 2013. In the multivariate analysis, elevated postoperative NLR (≥10.50) was confirmed as an independent prognostic factor for 3-year OS ( P = .001; hazard ratio [HR] 4.123, 95% confidence interval [CI] 1.750–9.567) and DFS ( P = .001; HR 3.342, 95% CI 1.619–6.898). In addition, for 3-year OS, both tumor grade and pN stage were confirmed as independent prognostic factors. And pN stage was confirmed as an independent prognostic factor for 3-year DFS. In conclusion, this study identified elevated postoperative NLR is associated with a poor prognosis in patients with synCRC underwent surgery resection, and the NLR provides improved accuracy for predicting clinical outcomes to stratify patients into different risk categories.
机译:在许多类型的癌症中,系统性炎症反应标记物被认为是信息最丰富的预后因素。然而,在同步性结直肠癌(synCRC)中,炎症标志物的预后价值包括预后营养指数(PNI),中性白细胞与淋巴细胞比(NLR),衍生的中性白细胞与淋巴细胞比(d-NLR),血小板与淋巴细胞比率(PLR)和淋巴细胞与单核细胞比率(LMR)很少进行评估。因此,本研究回顾了我们连续的synCRC患者,以探讨这些因素的预后价值。主要终点为总体生存期(OS),无病生存期(DFS)被视为次要终点。进行接收者操作特征曲线分析以确定5个标记的最佳截止水平。 Kaplan–Meier生存曲线和Cox比例风险模型用于评估OS,DFS和炎症标志物之间的关系。 2009年10月至2013年5月,在5742例接受结直肠癌手术的患者中,总共鉴定出114例经病理证实的synCRC病人。在多因素分析中,术后NLR(≥10.50)升高被确认为独立的预后因素。三年OS(P = .001;危险比[HR] 4.123,95%置信区间[CI] 1.750–9.567)和DFS(P = .001; HR 3.342,95%CI 1.619–6.898)。此外,对于3年OS,肿瘤分级和pN分期均被确认为独立的预后因素。 pN分期被确认为3年DFS的独立预后因素。综上所述,本研究确定了手术切除的synCRC患者术后NLR升高与预后不良有关,并且NLR为预测将患者分为不同风险类别的临床结果提供了更高的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号